Report copyright - A Randomized Open Label Phase II Trial of Aprepitant ...Emend (Aprepitant) is a substance P/neurokinin 1(NK1) receptor antagonist. It has little or no affinity for 5-HT3, corticosteroid
Please pass captcha verification before submit form